Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer - A single center randomized study


Kanat O., Evrensel T. , Baran I., Coskun H., Zarifoglu M., Turan O., ...More

MEDICAL ONCOLOGY, vol.20, no.3, pp.237-245, 2003 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 3
  • Publication Date: 2003
  • Doi Number: 10.1385/mo:20:3:237
  • Title of Journal : MEDICAL ONCOLOGY
  • Page Numbers: pp.237-245
  • Keywords: amifostine, paclitaxel, carboplatin, CISPLATIN PLUS VINORELBINE, PHASE-II, TRIAL, COMBINATION, INFUSION, 1-HOUR, DAMAGE, AGENT, HEAD

Abstract

Aim: In this study we determined the protective role of amifostine against the side effects of the combination of paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC).